Navigation Links
Neuroprotection - Drugs, Markets and Companies - Updated 2013 Report with Extra Company Collaborations
Date:8/9/2013

DUBLIN, August 9, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/5f7vxx/neuroprotection) have announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues are similar in all these conditions and several products are used in more than one disorder. Over 500 products have been investigated for neuroprotective effects including those from the categories of free radical scavengers, anti-excitotoxic agents, apoptosis (programmed cell death) inhibitors, anti-inflammatory agents, neurotrophic factors, metal ion chelators, ion channel modulators and gene therapy. Some of the agents are old established pharmaceuticals whereas others are new biotechnology products.

Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

The report contains profiles of 136 companies that have a neuroprotective product or products along with 120 collaborations. Some of the products in development at academic institutions that do not have a commercial sponsor are also included. Although an up-to-date search of the literature was performed and selected 1,000 references are included. Clinical trials of various neuroprotective agents are described and failures of trials are analyzed with suggestions for improving the selection of drugs and design of trials. The report is supplemented with 67 tables and 13 figures.

Market analysis of currently used products that have a neuroprotective effect are analyzed for the year 2012. Some of these products are approved for other indications but are known to have a neuroprotective effect. With the approval of new products and takeover of markets for obsolete symptomatic therapies, the neuroprotection market value will rise by the year 2017 when it will constitute a major and important component of the CNS market. Forecasts are made until 2022. By that time neuroprotection will be an established part of the neurological practice and measures will be available to achieve this effectively.

Key Topics Covered:

Part I: Drugs & Markets

Executive Summary

1. Introduction
2. Neuroprotective Agents
3. Neuroprotection in Cerebrovascular Disease
4. Neuroprotection in Traumatic Brain Injury
5. Neuroprotection in Spinal Cord Injury
6. Neuroprotection in Neurodegenerative Disorders
7. Neuroprotection in Parkinson Disease
8. Neuroprotection in Alzheimer Disease
9. Neuroprotection in Huntington Disease
10. Neuroprotection in Amyotrophic Lateral Sclerosis
11. Neuroprotection in Miscellaneous Neurological Disorders
12. Neuroprotection of the Optic nerve and the Retina
13. Neuroprotection during Anesthesia and Surgery
14. Markets for Neuroprotective Therapies
15. References

Part II: Companies

16. Companies Developing Neuroprotective Therapies

For more information visit http://www.researchandmarkets.com/research/5f7vxx/neuroprotection

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Alzheimer Disease - New Drugs, Markets and Companies - 2013
2. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
3. RNAi - Technologies, Markets and Companies - Updated 2012 Report
4. Life Science Software - 2013 Market Report: Markets and Opportunities
5. Cytogenetics - Technologies, Markets and Companies - 2013
6. Biomarkers - Technologies, Markets and Companies - Updated 2012 Report
7. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
8. Next Generation Sequencing: Emerging Clinical Applications and Global Markets
9. Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles
10. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
11. DNA Sequencing: Technologies, Markets and Companies - 2013 Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... Parks Associates announced today that Tom Kerber , Director ... , October 11 in Scottsdale, Arizona . Kerber will ... safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction of ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will feature ... Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ... how to continue to feed a growing nation. At the same time, many of ...
Breaking Biology Technology:
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):